nearly-every

Exclusive: Pfizer weighs sale or spin-off of consumer health unit – sources

By Lauren Hirsch, Olivia Oran and Carl O'Donnell (Reuters) – U.S. drugmaker Pfizer Inc is evaluating a potential sale or spin-off of its consumer health division that could value the unit at as much as $14 billion, people familiar with the matter said on Wednesday. A Pfizer exit from the consumer health business, which includes lip balm Chapstick and painkiller Advil, would be one of its biggest corporate moves since abandoning a $160 billion deal to buy Irish drugmaker Allergan Inc earlier this year…

Read the original:
Exclusive: Pfizer weighs sale or spin-off of consumer health unit – sources

nearly-every

Twitter says COO Adam Bain to leave, Noto to take his place

Twitter Inc said on Wednesday that Chief Operating Officer Adam Bain, widely credited with building a robust advertising business at the company even as it struggled with user growth, is leaving to explore other opportunities. “Mr. Bain will remain at Twitter in the coming weeks to assist with the transition of the chief operating officer role,” the company said. The move is a blow for struggling Twitter, which

Excerpt from: 
Twitter says COO Adam Bain to leave, Noto to take his place

nearly-every

Fed to proceed with December U.S. rate rise despite Trump upset: Reuters poll

While there was no prior official view on what the Fed would do if Trump won in a contest where nearly every poll of U.S. voters pointed to a victory for Democrat Hillary Clinton, many had said ensuing uncertainty from an upset might put up a roadblock. When the Fed last hiked, its first in the current cycle off the zero bound, it expected to have delivered four more by now, but was thrown off course several times throughout the year. Inflation has not picked …

Go here to see the original: 
Fed to proceed with December U.S. rate rise despite Trump upset: Reuters poll